Amgen Inc. (FRA:AMG)
242.25
-4.00 (-1.62%)
At close: May 13, 2025, 10:00 PM CET
Amgen Employees
Amgen had 28,000 employees as of December 31, 2024. The number of employees increased by 1,300 or 4.87% compared to the previous year.
Employees
28,000
Change (1Y)
1,300
Growth (1Y)
4.87%
Revenue / Employee
€1,127,621
Profits / Employee
€196,043
Market Cap
132.86B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Merck KGaA | 59,020 |
Amgen News
- 1 day ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 1 day ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ
- 1 day ago - European pharma stocks follow Asia peers down as Trump moves to cut prices - Reuters
- 4 days ago - AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE - PRNewsWire
- 5 days ago - Amgen CEO Robert A. Bradway to Receive Honorary Degree from KGI - GlobeNewsWire
- 6 days ago - Amgen’s Tepezza becomes first U.K.-medicine approved for adults with thyroid eye disease - Seeking Alpha
- 6 days ago - What the Options Market Tells Us About Amgen - Benzinga
- 6 days ago - Amgen's TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom - Business Wire